TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02832596 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT02832596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03865511 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03865511 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03865511 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04291833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04860583 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03879577 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00686218 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00002836 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01617655 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01617655 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00289900 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00448370 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT04588363 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04901052 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01778985 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study NCT03554109 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01065155 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02726269 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03686111 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT03686111 — Predictive Biomarker (PRD): LMNB1 mRNA
Genes: LMNB1; LMN2; LMNB
Study NCT03686111 — Predictive Biomarker (PRD): LMNB2 mRNA
Genes: LMNB2; LMN2
Study NCT04822909 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04822909 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT02455089 — Predictive Biomarker (PRD): PPP1R15A mRNA
Genes: PPP1R15A; GADD34
Study NCT02346916 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT03548415 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study NCT03548415 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT03548415 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01770730 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01099891 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02663479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00118859 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT03780062 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02394795 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02394795 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00500110 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT04228653 — Predictive Biomarker (PRD): CDNF mRNA
Genes: CDNF; ARMETL1
Study NCT00001911 — Safety Biomarker (SAF): Interleukin 12
Study NCT00001911 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00003091 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03476252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03476252 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT04385836 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04385836 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT04385836 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02307435 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01666652 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03753503 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03753503 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT03753503 — Safety Biomarker (SAF): BDNF
Study NCT04066244 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04106765 — Predictive Biomarker (PRD): LGI1 mRNA
Genes: LGI1; EPT; UNQ775/PRO1569
Study NCT01163500 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02882516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02787798 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03545581 — Predictive Biomarker (PRD): ALDOB mRNA
Genes: ALDOB; ALDB
Study NCT00110578 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03553550 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00045487 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03830411 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02067741 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00425854 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00425854 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03811873 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00286689 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00592917 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00592917 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00004732 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02948075 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02186171 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00954135 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00954135 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04448743 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study NCT04448743 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT01043848 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01277497 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02379897 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03318419 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00672269 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT01385280 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00668174 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT04457193 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT01129284 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03167164 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT03167164 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00422461 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04242602 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00908388 — Predictive Biomarker (PRD): CTAG1B mRNA
Genes: CTAG1A; CTAG; CTAG1; ESO1; LAGE2; LAGE2A; CTAG1B; LAGE2B
Study NCT00832962 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT02673450 — Predictive Biomarker (PRD): PER3 mRNA
Genes: PER3; GIG13
Study NCT04250389 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT01653002 — Predictive Biomarker (PRD): SHOX2 mRNA
Genes: SHOX2; OG12X; SHOT
Study NCT04929418 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03920878 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03920878 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03212469 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03479346 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT04354688 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT05033535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02553317 — Surrogate Endpoint (SUR): Platelet count response
Study NCT01232842 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT02963363 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00400439 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00563212 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00337194 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00004032 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02476682 — Predictive Biomarker (PRD): AMN mRNA
Genes: AMN; UNQ513/PRO1028
Study NCT03471481 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01539889 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT00617838 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT00125372 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00487630 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT05986058 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03610906 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study NCT00201773 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study NCT00180700 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04416139 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04416139 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04416139 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03725059 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03725059 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03725059 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01009242 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02138149 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT03039920 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT00360048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00777673 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01169961 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00714298 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Heart fatty acid-binding protein
Genes: FABP3; FABP11; MDGI
Study NCT03203590 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00571792 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT02145611 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04299321 — Predictive Biomarker (PRD): LAMA2 mRNA
Genes: LAMA2; LAMM
Study NCT01935154 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT01935154 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03383133 — Predictive Biomarker (PRD): SULT1A1 mRNA
Genes: SULT1A1; STP; STP1; OK/SW-cl.88
Study NCT03383133 — Predictive Biomarker (PRD): SULT2A1 mRNA
Genes: SULT2A1; HST; STD
Study NCT03464448 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01489358 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00051350 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03623425 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00700232 — Predictive Biomarker (PRD): ABCB4 mRNA
Genes: ABCB4; MDR3; PGY3
Study NCT00000544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00472251 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05282407 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01932931 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02975700 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01817452 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01817452 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05622357 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01925612 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00147797 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01014949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01250314 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04303403 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT04303403 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04382079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04382079 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT01433003 — Predictive Biomarker (PRD): ZFP36 mRNA
Genes: ZFP36; G0S24; NUP475; RNF162A; TIS11A; TTP
Study NCT02979600 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01078740 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03383081 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00527878 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03971045 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03971045 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03971045 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04514549 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT00599170 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03921541 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study NCT03388788 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03506633 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04029038 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04029038 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT00504231 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT00178542 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01038466 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02415803 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT03091491 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03091491 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03309111 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03268161 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study NCT03268161 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT00421733 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02928926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03848351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02334410 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01854593 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04555369 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01404260 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01404260 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01749566 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01520584 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01795131 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01990352 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00949078 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01641757 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01038895 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00863421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04540900 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study NCT04362150 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00610038 — Predictive Biomarker (PRD): ABCC8 mRNA
Genes: ABCC8; HRINS; SUR; SUR1
Study NCT04909411 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT00047632 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02048813 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00559416 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00559416 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT00113126 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03978156 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03081923 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03081923 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03983070 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02205398 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02205398 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01823770 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02133742 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00779883 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT00372515 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01064284 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04199039 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04199039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03830970 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT00084279 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03034876 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01277848 — Predictive Biomarker (PRD): PLAC1 mRNA
Genes: PLAC1
Study NCT06393894 — Predictive Biomarker (PRD): miR-145
Genes: MIR145
Study NCT06393894 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT00171028 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03443609 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03428451 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03041480 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01667458 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04254432 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00275899 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00002461 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04605939 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03660982 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT01760187 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00303615 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03288025 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01740427 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01740427 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study NCT01740427 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT02062398 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT00961870 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04086667 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT04086667 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT03508453 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT04633876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01290354 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01200134 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01306994 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01306994 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01744457 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00990379 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT00990379 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study NCT00990379 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT02340676 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01357681 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02402231 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01925820 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02992431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04553536 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1